कृपया अन्य खोज का प्रयास करें
Celyad Oncology SA, a biopharmaceutical company, focuses on the research and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. The company is developing shRNA non-gene-edited technology, which allows for the development of allogenic CAR T-cells through the modulation of genes encoding the TCR without the need for gene editing; Multi-specific CAR T-cell platform that focuses on the NKG2D receptor; NKG2D-based CAR T-cell therapies; and B7-H6 targeting CAT T-cell therapies. It has licensing agreement with Novartis International AG regarding the United States patents related to allogeneic CAR-T cells; and research and development collaboration, and license agreements with Horizon Discovery / PerkinElmer for the use of its shRNA reagents to reduce expression of one or more defined targets. The company was formerly known as Celyad SA and changed its name to Celyad Oncology SA in June 2020. Celyad Oncology SA was founded in 2004 and is headquartered in Mont-Saint-Guibert, Belgium.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Michel E. J. Lussier | 68 | 2007 | Co-Founder, Interim CEO & Executive Director |
Marco L. Davila | - | 2016 | Member of Scientific Advisory Board |
Serge Goblet | 66 | 2008 | Non-Executive Director |
Hinrich Abken | - | 2016 | Member of Scientific Advisory Board |
Marina Udier Blagovic | - | 2020 | Independent Director |
Hilde Windels | 59 | 2017 | Independent Chairwoman of the Board |
Dominic G. Piscitelli | 49 | 2020 | Independent Director |
Christopher LiPuma | - | 2022 | Non-Executive Director |
Margo R. Roberts | 69 | 2018 | Member of Scientific Advisory Board |
Gerry Graham | - | - | Member of Scientific Advisory Board |
Ann Ager | - | - | Member of Scientific Advisory Board |
Ami Patel Shah | - | 2021 | Non-Executive Director |
Jean-Christophe Marine | - | - | Member of Scientific Advisory Board |
Andrea Gothing | - | 2024 | Non-Executive Director |
John Campbell | - | - | Member of Scientific Advisory Board |
Jonathan James | - | 2024 | Non-Executive Director |
Sage Mandel | - | 2024 | Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है